|
Real-time Estimate
Cboe BZX
23:04:17 13/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.005 USD | -2.44% |
|
+3.45% | +5.86% |
| 11-05 | Evolus, Inc., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-05 | Evolus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOLUS, INC. | Other Pharmaceuticals | -2.09% | +3.45% | +5.86% | -4.48% | -0.85% | 475M |  | |  |
- Stock Market
- Stocks
- EOLS Stock
- Charts Evolus, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
